vs
Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $9.1M, roughly 1.6× Protalix BioTherapeutics, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -60.3%, a 124.6% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -49.9%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $1.6M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs -6.7%).
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
IDR vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $9.1M |
| Net Profit | $9.4M | $-5.5M |
| Gross Margin | 68.5% | 49.4% |
| Operating Margin | 62.4% | -51.1% |
| Net Margin | 64.3% | -60.3% |
| Revenue YoY | 92.0% | -49.9% |
| Net Profit YoY | 220.6% | -184.8% |
| EPS (diluted) | $0.62 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.6M | $9.1M | ||
| Q3 25 | $11.1M | $17.9M | ||
| Q2 25 | $9.5M | $15.7M | ||
| Q1 25 | $7.3M | $10.1M | ||
| Q4 24 | $7.6M | $18.2M | ||
| Q3 24 | $6.2M | $18.0M | ||
| Q2 24 | $6.1M | $13.5M | ||
| Q1 24 | $5.9M | — |
| Q4 25 | $9.4M | $-5.5M | ||
| Q3 25 | $3.0M | $2.4M | ||
| Q2 25 | $2.8M | $164.0K | ||
| Q1 25 | $1.6M | $-3.6M | ||
| Q4 24 | $2.9M | $6.5M | ||
| Q3 24 | $1.6M | $3.2M | ||
| Q2 24 | $2.2M | $-2.2M | ||
| Q1 24 | $2.2M | — |
| Q4 25 | 68.5% | 49.4% | ||
| Q3 25 | 63.6% | 53.4% | ||
| Q2 25 | 57.8% | 62.5% | ||
| Q1 25 | 50.8% | 19.1% | ||
| Q4 24 | 53.3% | 78.7% | ||
| Q3 24 | 48.7% | 53.4% | ||
| Q2 24 | 50.2% | 29.8% | ||
| Q1 24 | 48.1% | — |
| Q4 25 | 62.4% | -51.1% | ||
| Q3 25 | 23.4% | 11.9% | ||
| Q2 25 | 26.6% | 7.5% | ||
| Q1 25 | 19.3% | -41.0% | ||
| Q4 24 | 36.2% | 39.6% | ||
| Q3 24 | 23.4% | 22.2% | ||
| Q2 24 | 34.2% | -18.0% | ||
| Q1 24 | 36.3% | — |
| Q4 25 | 64.3% | -60.3% | ||
| Q3 25 | 26.8% | 13.2% | ||
| Q2 25 | 29.2% | 1.0% | ||
| Q1 25 | 22.1% | -35.8% | ||
| Q4 24 | 38.5% | 35.6% | ||
| Q3 24 | 25.8% | 18.0% | ||
| Q2 24 | 35.2% | -16.4% | ||
| Q1 24 | 36.8% | — |
| Q4 25 | $0.62 | $-0.06 | ||
| Q3 25 | $0.20 | $0.03 | ||
| Q2 25 | $0.20 | $0.00 | ||
| Q1 25 | $0.12 | $-0.05 | ||
| Q4 24 | $0.21 | $0.10 | ||
| Q3 24 | $0.12 | $0.03 | ||
| Q2 24 | $0.17 | $-0.03 | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $14.7M |
| Total DebtLower is stronger | $2.3M | — |
| Stockholders' EquityBook value | $108.2M | $48.2M |
| Total Assets | $116.2M | $82.3M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | $6.3M | $23.4M | ||
| Q1 24 | $5.3M | — |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | $108.2M | $48.2M | ||
| Q3 25 | $74.3M | $52.9M | ||
| Q2 25 | $49.3M | $49.9M | ||
| Q1 25 | $39.8M | $45.2M | ||
| Q4 24 | $37.7M | $43.2M | ||
| Q3 24 | $33.1M | $32.4M | ||
| Q2 24 | $25.4M | $28.6M | ||
| Q1 24 | $21.6M | — |
| Q4 25 | $116.2M | $82.3M | ||
| Q3 25 | $83.1M | $82.3M | ||
| Q2 25 | $57.7M | $78.5M | ||
| Q1 25 | $48.1M | $73.9M | ||
| Q4 24 | $44.0M | $73.4M | ||
| Q3 24 | $40.8M | $61.6M | ||
| Q2 24 | $32.2M | $91.5M | ||
| Q1 24 | $28.7M | — |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.7M | $2.0M |
| Free Cash FlowOCF − Capex | $8.2M | $1.6M |
| FCF MarginFCF / Revenue | 56.0% | 17.8% |
| Capex IntensityCapex / Revenue | 17.7% | 4.4% |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.4M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | $2.0M | ||
| Q3 25 | $2.4M | $-3.7M | ||
| Q2 25 | $3.5M | $-5.2M | ||
| Q1 25 | $2.4M | $-5.1M | ||
| Q4 24 | $3.2M | $4.0M | ||
| Q3 24 | $2.5M | $4.1M | ||
| Q2 24 | $2.6M | $-3.6M | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $8.2M | $1.6M | ||
| Q3 25 | $709.8K | $-4.2M | ||
| Q2 25 | $2.5M | $-5.7M | ||
| Q1 25 | $1.0M | $-5.4M | ||
| Q4 24 | $2.1M | $3.6M | ||
| Q3 24 | $1.9M | $4.0M | ||
| Q2 24 | $2.4M | $-3.8M | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 56.0% | 17.8% | ||
| Q3 25 | 6.4% | -23.7% | ||
| Q2 25 | 26.5% | -36.2% | ||
| Q1 25 | 13.8% | -53.0% | ||
| Q4 24 | 28.0% | 19.6% | ||
| Q3 24 | 30.4% | 22.4% | ||
| Q2 24 | 38.7% | -28.1% | ||
| Q1 24 | 38.3% | — |
| Q4 25 | 17.7% | 4.4% | ||
| Q3 25 | 15.3% | 2.8% | ||
| Q2 25 | 10.8% | 2.8% | ||
| Q1 25 | 19.4% | 3.0% | ||
| Q4 24 | 13.6% | 2.3% | ||
| Q3 24 | 9.8% | 0.5% | ||
| Q2 24 | 4.3% | 1.3% | ||
| Q1 24 | 5.5% | — |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 0.81× | -1.58× | ||
| Q2 25 | 1.28× | -31.91× | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | 0.61× | ||
| Q3 24 | 1.56× | 1.27× | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDR
Segment breakdown not available.
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
